Multivariate analysis of recurrence factors for non-muscle-invasive bladder urothelial carcinomas

National Medical Journal of China

Volumn 90, Issue 28, 2010, Pages 1992-1994

  Chen, Jun Xing ^a   Deng, Nan ^a   Chen, Ling Wu ^a   Qiu, Shao Peng ^a   Li, Xiao Fei ^a   Chen, Wei ^a   Dai, Yu Ping ^a   Liang, Yue You ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Bladder neoplasms; Multivariate analysis; Recurrence

Indexed keywords

ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NON MUSCLE INVASIVE BLADDER CANCER; RETROSPECTIVE STUDY; RISK FACTOR; TUMOR RECURRENCE; ADULT; AGED; BLADDER TUMOR; DISEASE FREE SURVIVAL; FEMALE; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84871414619     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2010.28.014     Document Type: Article

References (14)

1. Louis R, Andrew C, Atan W, et al. Campbell-Walsh Urology. 9th ed. USA: Elsevier Inc, 2007:2447-2467.
2. Burger M, van der Aa M N, van Oers J M, et al. Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study. Eur Urol, 2008, 54:835-844.
3. Sorbin D H, Witteking C H. TNM classification of Malignant Tumors. 6th ed. New York: Wiley-Liss, 2002:199-202.
4. Oosterlinck W, Witjes F, Sylvester R, et al. Diagnostic and prognostic factors in non-muscle-invasive bladder cancer and their influence on treatment and outcomes. Eur Urol, 2008, 7 Suppl 7: 516-523.
5. Louis L S. Urothelial cancer biomarkers for detection and surveillance. Urology, 2006, 67(3 Suppl 1):25-34.
6. Mitra A P, Datar R H, Cote R J. Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J Clin Oncol, 2006, 24:5552-5564.
7. 2004, 41: 893-896.
8. 2006, 86: 1305-1308.
9. Queipo Z, Ruiz C, Palmero M, et al. Prognostic value for progression of the regulating p roteins of the cellular cycle in PT1G3 bladder tumors. Actas Urol Esp, 2005, 29: 261-268.
10. Solsona E, Iborra I, Dumont R, et al. The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer. J Urol, 2000, 164: 685-689.
11. Braasch M R, Bohle A, O'Donnell M A. Intravesical instillation treatment of non-muscle-invasive bladder cancer. Eur Urol, 2009, 7 Suppl 8:549-555.
12. Kirkali Z, Chan T, Manoharan M, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology, 2005, 66:4-34.
13. 2003, 25: 475-477.
14. Rodriguez-Alonso A, Pita-Fernandez S, Gonzalez-Carrero J, et al. Multivariate analysis of survival, recurrence, progression and development of mestastasis in T1 and T2a transitional cell bladder carcinoma. Cancer, 2002, 94: 1677-1684.